[ET Net News Agency, 3 June 2025] J.P. Morgan raised the target price for Innovent Bio  
(01801) to HKD74 from HKD55 and maintained the "overweight" rating. 
  The research house said it lifts sales forecast for 29-33E by 7-45%, while keeping  
margin assumption largely unchanged. (rc)